Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Aktas

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|March 29, 2014
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitorsKhuloud Takrouri, Ting Chen, Evangelos Papadopoulos, et al.
Journal of Medicinal Chemistry|November 23, 2013
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinaseTing Chen, Khuloud Takrouri, Sung Hee-Hwang, et al.
Cancer Research|January 22, 2011
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysisWeiguo Hu, Xiaowen Ge, Tao You, et al.
Nature Chemical Biology|July 19, 2011
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer targetTing Chen, Duygu Ozel, Yuan Qiao, et al.
Oncotarget|September 1, 2012
Tumor suppression by small molecule inhibitors of translation initiationLimo Chen, Bertal H Aktas, Yibo Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4GEvangelos Papadopoulos, Simon Jenni, Eihab Kabha, et al.
Scientific Reports|December 8, 2017
Emerging Role for the PERK/eIF2α/ATF4 in Human Cutaneous LeishmaniasisKarina Luiza Dias-Teixeira, Teresa C Calegari-Silva, Jorge M Medina, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Theranostics|August 2, 2021
Endothelial cell infection and dysfunction, immune activation in severe COVID-19Zhongnan Qin, Fengming Liu, Robert Blair, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
SARS-CoV-2 Infects Endothelial Cells <i>In Vivo</i> and <i>In Vitro</i>Fengming Liu, Kun Han, Robert Blair, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|March 29, 2014
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitorsKhuloud Takrouri, Ting Chen, Evangelos Papadopoulos, et al.
Journal of Medicinal Chemistry|November 23, 2013
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinaseTing Chen, Khuloud Takrouri, Sung Hee-Hwang, et al.
Cancer Research|January 22, 2011
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysisWeiguo Hu, Xiaowen Ge, Tao You, et al.
Nature Chemical Biology|July 19, 2011
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer targetTing Chen, Duygu Ozel, Yuan Qiao, et al.
Oncotarget|September 1, 2012
Tumor suppression by small molecule inhibitors of translation initiationLimo Chen, Bertal H Aktas, Yibo Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4GEvangelos Papadopoulos, Simon Jenni, Eihab Kabha, et al.
Scientific Reports|December 8, 2017
Emerging Role for the PERK/eIF2α/ATF4 in Human Cutaneous LeishmaniasisKarina Luiza Dias-Teixeira, Teresa C Calegari-Silva, Jorge M Medina, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Theranostics|August 2, 2021
Endothelial cell infection and dysfunction, immune activation in severe COVID-19Zhongnan Qin, Fengming Liu, Robert Blair, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
SARS-CoV-2 Infects Endothelial Cells <i>In Vivo</i> and <i>In Vitro</i>Fengming Liu, Kun Han, Robert Blair, et al.
Pageof 6